Par Drugs & Chemicals Ltd

₹ 113 4.99%

09 Nov - close price

About

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals^[1]

Key Points

Business Overview:^[1]^[2]^[3]
The company manufactures Active Pharmaceutical Ingredients (APIs) and fine chemicals, primarily serving the antacid molecules segment. The company offers 18 APIs and 10 fine chemicals for domestic and international markets, used in pharmaceutical formulations such as tablets, capsules and liquids.

Website NSE - BE

Market Cap ₹ 139 Cr.
Current Price ₹ 113
High / Low ₹ 180 / 78.0
Stock P/E 10.7
Book Value ₹ 97.0
Dividend Yield 0.00 %
ROCE 14.6 %
ROE 9.95 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Stock is trading at 1.17 times its book value

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 11.3% over past five years.
Company has a low return on equity of 13.4% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	25.89	24.00	22.82	22.61	34.66	21.38	22.33	26.05	28.66	29.34	19.61	31.28	27.43
YoY Sales growth	+4.31%	+4.67%	-6.82%	-1.40%	+33.87%	-10.92%	-2.15%	+15.21%	-17.31%	+37.23%	-12.18%	+20.08%	-4.29%
	18.53	18.77	16.72	18.37	23.25	19.95	19.90	22.49	22.60	23.29	18.17	24.91	22.92
Operating Profit	7.36	5.23	6.10	4.24	11.41	1.43	2.43	3.56	6.06	6.05	1.44	6.37	4.51
OPM %	28.43%	21.79%	26.73%	18.75%	32.92%	6.69%	10.88%	13.67%	21.14%	20.62%	7.34%	20.36%	16.44%
	0.05	0.23	-0.05	0.07	1.02	0.27	0.79	1.84	0.48	1.33	0.36	0.94	0.00
Interest	0.03	0.02	0.05	0.02	0.03	0.01	0.02	0.02	0.05	0.01	0.04	0.02	0.02
Depreciation	0.85	0.87	0.89	0.90	0.91	0.91	0.92	0.90	0.94	0.93	0.93	0.96	0.94
Profit before tax	6.53	4.57	5.11	3.39	11.49	0.78	2.28	4.48	5.55	6.44	0.83	6.33	3.55
Tax %	25.27%	25.16%	27.20%	25.07%	25.15%	24.36%	27.63%	25.67%	25.59%	25.47%	-3.61%	25.59%	25.92%
	4.89	3.42	3.72	2.53	8.60	0.58	1.65	3.33	4.13	4.80	0.85	4.71	2.63
EPS in Rs	3.97	2.78	3.02	2.06	6.99	0.47	1.34	2.71	3.36	3.90	0.69	3.83	2.14
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	33	33	49	42	46	56	61	75	96	96	101	104	108
Sales growth	+22%	+0%	+47%	-13%	+9%	+21%	+9%	+24%	+28%	-0%	+6%	+3%	+9%
	26	26	40	34	38	46	45	59	78	73	81	87	89
Operating Profit	7	7	8	8	8	9	16	16	18	23	20	17	18
OPM %	22%	22%	17%	19%	18%	17%	26%	22%	19%	24%	19%	17%	17%
	0	0	0	0	0	0	2	0	0	0	2	4	3
Interest	4	4	2	2	2	1	1	0	0	0	0	0	0
Depreciation	2	3	3	3	3	3	3	3	3	3	4	4	4
Profit before tax	1	1	3	3	3	6	15	13	15	20	18	17	17
Tax %	27%	58%	42%	42%	24%	21%	21%	27%	25%	26%	26%	24%
	1	0	2	2	3	5	12	9	11	14	13	13	13
EPS in Rs	1.65	0.78	3.43	2.78	2.79	3.87	9.44	7.49	9.21	11.78	10.86	10.65	10.56
Dividend Payout %	0%	0%	0%	0%	0%	32%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	12%
5 Years:	11%
3 Years:	3%
TTM:	9%

Compounded Profit Growth
10 Years:	38%
5 Years:	1%
3 Years:	-2%
TTM:	34%

Stock Price CAGR
10 Years:	%
5 Years:	-14%
3 Years:	-20%
1 Year:	15%

Return on Equity
10 Years:	15%
5 Years:	14%
3 Years:	13%
Last Year:	10%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
Equity Capital	3	3	3	3	4	6	6	12	12	12	12	12	12
Reserves	9	9	11	12	25	34	46	48	59	73	87	100	107
	38	36	31	29	12	6	8	0	0	0	0	0	0
	9	10	12	10	11	13	16	19	18	16	20	17	19
Total Liabilities	59	58	56	54	51	60	76	79	89	102	119	129	139
	45	43	42	39	36	34	30	34	38	41	39	36	36
CWIP	0	0	0	0	0	1	5	0	0	0	0	1	0
Investments	0	0	0	0	0	0	0	0	0	0	25	27	35
	13	15	14	15	15	25	42	44	50	60	55	65	68
Total Assets	59	58	56	54	51	60	76	79	89	102	119	129	139

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	9	7	9	4	2	8	12	8	13	20	16	16
	-0	-0	-2	-1	-0	-1	0	-3	-7	-6	-25	-2
	-9	-5	-8	-4	-2	1	2	-10	0	0	0	0
Net Cash Flow	-1	1	-1	0	-0	7	14	-5	6	14	-9	14
Free Cash Flow	9	6	7	4	2	6	12	4	6	14	15	14
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	127%	91%	116%	59%	34%	90%	98%	66%	97%	108%	106%	125%

Ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	83	81	61	75	67	81	75	90	65	52	60	42
Inventory Days	111	158	69	83	81	45	50	60	49	45	58	45
Days Payable	184	183	135	107	94	96	112	135	73	58	104	69
Cash Conversion Cycle	10	57	-5	51	55	30	13	14	40	40	15	19
Working Capital Days	61	66	-46	-26	13	39	24	61	50	40	39	31
ROCE %	10%	9%	12%	11%	12%	16%	25%	22%	23%	25%	18%	15%

Insights

In beta

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Installed Manufacturing Capacity
MTPA

x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx
xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx		xx.xx	xx.xx
		xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
		xx	xx	xx	xx	xx	xx
		xxx	xxx	xxx	xxx	xxx	xxx
		xx	xx	xx	xx	xx	xx
		x	xx	xx	xx	xx	xx
xx.xx	xx.xx	xx.xx

Please log in to see hidden values.

API Revenue Share
% of operational revenue

Export Sales Share
% of total sales

Number of API Products
count

Number of Customers
count

Number of Export Countries
count

Number of Fine Chemical Products
count

Capacity Utilization
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	74.21%	74.21%	74.21%	73.37%	73.37%	73.37%	73.37%	73.37%	73.41%	73.41%	73.41%	73.41%
	0.07%	0.07%	0.32%	0.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00%	0.05%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.09%	0.09%
	25.73%	25.68%	25.47%	26.54%	26.63%	26.63%	26.63%	26.63%	26.59%	26.59%	26.51%	26.51%
No. of Shareholders	7,020	7,403	8,022	8,757	17,189	15,472	14,887	14,280	13,761	13,222	12,782	12,672

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
	73.12%	73.86%	74.21%	74.21%	74.21%	73.37%	73.41%	73.41%
	0.00%	0.00%	0.00%	0.00%	0.07%	0.00%	0.00%	0.00%
	0.00%	0.00%	0.05%	0.00%	0.05%	0.00%	0.00%	0.09%
	26.88%	26.14%	25.75%	25.79%	25.68%	26.63%	26.59%	26.51%
No. of Shareholders	400	289	4,034	5,585	7,403	15,472	13,222	12,672

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Jun 2023

Transcript

AI Summary
PPT
Jun 2023

Transcript

AI Summary
PPT
Mar 2023

Transcript

AI Summary
PPT
Mar 2023

Transcript

AI Summary
PPT
Feb 2023

Transcript

AI Summary
PPT
Nov 2022

Transcript

AI Summary
PPT
Nov 2022

Transcript

AI Summary
PPT
Aug 2022

Transcript

AI Summary
PPT
May 2022

Transcript

AI Summary
PPT
Feb 2022

Transcript

AI Summary
PPT
Dec 2021

Transcript

AI Summary
PPT
Nov 2021

Transcript

AI Summary
PPT
Jun 2021

Transcript

AI Summary
PPT
Nov 2020

Transcript

AI Summary
PPT
Nov 2020

Transcript

AI Summary
PPT
Jun 2020

Transcript

AI Summary
PPT
Sep 2019

Transcript

AI Summary
PPT